Damage-Free, Ultrasonic Cell Isolation from Retinal Pigment Epithelium (RPE) Monolayers,
Role: PD/PI,
University of Southern California,
(08/2023 - 02/2025)
Status: Awarded
Targeting HB-EGF and trigeminal EGFR for oral cancer pain and opioid tolerance,
Role: Consultant,
New York University,
(09/2022 - 09/2025)
Status: Awarded
Targeting HB-EGF and trigeminal EGFR for oral cancer pain and opioid tolerance,
Role: PD/PI,
New York University,
(09/2022 - 09/2025)
Status: Awarded
Targeting HB-EGF and trigeminal EGFR for oral cancer pain and opioid tolerance,
Role: SubProject PI,
New York University,
(09/2022 - 09/2025)
Status: Awarded
Federal
Supplement: Large scale single-cell gene rearrangement detection with a microfluidic device,
Role: PD/PI,
National Institutes of Health/DHHS,
(03/2022 - 02/2024)
Status: Awarded
Large scale single-cell gene rearrangement detection with a microfluidic device (R01CA251848),
Role: PD/PI,
National Cancer Institute/NIH/DHHS,
(08/2021 - 06/2025)
Status: Awarded
Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma (R01CA197903),
Role: PD/PI,
National Cancer Institute/NIH/DHHS,
(08/2021 - 06/2025)
Status: Awarded
Internal
Detection of alloreactive T lymphocyte clones to predict acute rejection after kidney transplantation,
Role: PD/PI,
LLU School of Medicine,
(04/2023 - 03/2026)
Status: Awarded
Non-Profit Organization
Integration of donor-derived cell-free DNA with HLA-DR+TNFR2+ regulatory T cell in the prediction of acute rejection and graft function after kidney transplantation,
Role: Investigator,
American Society of Transplant Surgeons,
(08/2024 - 08/2025)
Status: Approved